Pure Global AI
NCT05918458Not yet recruiting

Discovering Clinical Study Experiences of Patients With Pulmonary Hypertension

Pulmonary Hypertension Clinical Trials: What Are Prevailing Patient Experiences in Pulmonary Hypertension Studies
Power Life Sciences Inc.ClinicalTrials.gov
Verified
Study focus
Disease/Condition
Pulmonary Hypertension
Study type
Observational
Sponsor & location
Primary sponsor
Power Life Sciences Inc.
Location
San Francisco, United States of America
Timeline & enrollment
Phase
N/A
Start date
Jul 01, 2024
End date
Jul 01, 2026
Enrollment
500 participants
Primary outcome

Number of patients who decide to enroll in a pulmonary hypertension clinical research,Rate of patients who remain in pulmonary hypertension clinical research to trial completion

Summary

Taking part in medical trials usually favors a particular demographic group. But there is
 limited research available to explain what trial attributes affect the completion of these
 specific demographic groups.
 
 This study will admit a wide range of data on the clinical trial experience of pulmonary
 hypertension patients to determine which factors prevail in limiting a patient's ability to
 join or finish a trial.
 
 It will also try to analyze data from the perspective of different demographic groups to
 check for recurring trends which might yield insights for the sake of future pulmonary
 hypertension patients.

ICD-10 classifications
Primary pulmonary hypertensionOther secondary pulmonary hypertensionPulmonary heart disease and diseases of pulmonary circulationPulmonary heart disease, unspecifiedPulmonary valve disorders
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05918458
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05918458 through Pure Global AI's free database. This phase not specified trial is sponsored by Power Life Sciences Inc. and is currently Not yet recruiting. The study focuses on Pulmonary Hypertension. Target enrollment is 500 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.